Beck T.; Boumber Y.; Aggarwal C.; Pei J.; Thrash-Bingham C.; Fittipaldi P.; Vlasenkova R.; Rao C.; Borghaei H.; Cristofanilli M.; Mehra R.; Serebriiskii I.; Alpaugh R.
(2019)
© 2019 The Author(s). Background: Circulating tumor cells (CTC) and plasma cell-free RNA (cfRNA) can serve as biomarkers for prognosis and treatment response in lung cancer. One barrier to the selected or routine use of ...